Laboratory Corporation of America Holdings (LH)

Operating return on assets (Operating ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating income (ttm) US$ in thousands 736,800 1,225,500 1,347,200 1,509,700 1,856,600 2,221,300 2,614,200 2,889,500 3,259,500 3,822,100 4,102,300 3,695,900 2,445,400 1,488,600 781,400 819,400 1,330,200 1,301,500 1,305,000 1,338,500
Total assets US$ in thousands 16,725,100 16,886,000 17,718,700 20,200,000 20,155,100 19,826,000 20,403,100 20,728,400 20,385,400 20,866,500 20,417,100 20,417,100 20,071,700 18,739,600 17,849,100 17,298,400 18,046,400 17,847,800 17,744,400 16,970,800
Operating ROA 4.41% 7.26% 7.60% 7.47% 9.21% 11.20% 12.81% 13.94% 15.99% 18.32% 20.09% 18.10% 12.18% 7.94% 4.38% 4.74% 7.37% 7.29% 7.35% 7.89%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $736,800K ÷ $16,725,100K
= 4.41%

The operating return on assets (operating ROA) for Laboratory Corp. Of America Holdings has been gradually decreasing over the past eight quarters. Starting at a high of 14.12% in Q1 2022, the operating ROA has experienced a consistent downward trend, reaching its lowest point of 6.72% in Q4 2023. This decline suggests that the company may be experiencing challenges in generating operating income relative to its assets, which could be attributed to various factors such as operational inefficiencies, increased operating expenses, or a decline in revenue generation. Management may need to closely monitor and address these issues to improve the company's operating performance and profitability.


Peer comparison

Dec 31, 2023

Company name
Symbol
Operating ROA
Laboratory Corporation of America Holdings
LH
4.41%
Fulgent Genetics Inc
FLGT
-15.83%
Quest Diagnostics Incorporated
DGX
9.00%
RadNet Inc
RDNT
3.67%